Comparing robotic and video-assisted lung surgery techniques
Official title: Robotic Versus Video-assisted Lobectomy/Segmentectomy for Lung Surgery
Run by The Second Hospital of Shandong University · NCT05270616 · Data updated 2026-11-12
This study is testing whether robotic lung surgery works better and is safer than video-assisted lung surgery for patients needing lung removal.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 800 (estimated) |
| Sponsor | The Second Hospital of Shandong University Academic / other |
| Locations | 1 site (Jinan, Shandong) |
| Status | Recruiting |
| Started | June 1, 2020 |
| Main results expected | June 1, 2023 |
| Study ends | June 1, 2028 |
| Registry record updated | March 8, 2022 |
| Trial ID | NCT05270616 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients with good cardio-pulmonary function who require minimally invasive lobectomy or segmentectomy.
✕Probably not a fit
Patients with poor cardio-pulmonary function or those with large tumors or extensive adhesions in the thoracic cavity may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to compare the safety and efficacy of robotic-assisted lobectomy/segmentectomy (RAL/S) with video-assisted lobectomy/segmentectomy (VAL/S) for lung resection. The VAL/S approach is further divided into uniport and multiport techniques. By evaluating these two minimally invasive surgical methods, the study seeks to determine which approach offers better outcomes for patients undergoing lung surgery.
Why it matters
Potential benefit: If successful, this study could lead to improved surgical outcomes and recovery for patients undergoing lung resection.
How similar studies have gone: Other studies have shown promising results with robotic and video-assisted surgical techniques, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. good cardio- pulmonary function to tolerate surgery; 2. minimaly invasive surgery for lobectomy or segmentectomy or sleeve lobectomy; Exclusion Criteria: 1. cardio- pulmonary function is not good enough to tolerate surgery; 2. huge tumor or extensive adhesion in thoracic cavity.
Where it's running
-
The Second Hospital of Shandong University
Jinan, Shandong, China Recruiting
Study contacts
- Study coordinator: Xiaogang Zhao
- Email: zhaoxiaogang@sdu.edu.cn
- Phone: +8617660080007
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Electrical Impedance Tomography for Monitoring Lung Disease
This test tries to see if a painless, noninvasive imaging method called electrical impedance tomography (EIT) can track how air is distributed in the lungs of adults with lung diseases and healthy volunteers and how those results match standard spirometry.
-
Mosliciguat added to inhaled treprostinil for pulmonary hypertension from ILD
This trial tests whether adding inhaled mosliciguat to your inhaled treprostinil is safe and tolerable for people with pulmonary hypertension caused by interstitial lung disease.
-
Collecting lung sound recordings using Eko digital stethoscopes in clinic
This project will try to teach computer programs to recognize wheeze, crackles, rhonchi, stridor, rales, and cough from stethoscope recordings in adults with suspected or diagnosed lung conditions and in people with normal lungs.
-
Multi-omics prediction of graft problems after lung transplant
We will test whether repeated blood and lung-fluid multi-omics tests can spot early graft dysfunction in adults after lung transplantation.
-
Recording lung sounds with Eko digital stethoscopes in clinic
This project will test an AI that listens to lung sounds recorded with Eko digital stethoscopes to find abnormal sounds in people with or without lung disease.
-
Trop2- and EpCAM-targeted PET/CT to help distinguish non-small cell lung cancer
This project will test whether PET/CT scans that target Trop2 and EpCAM can show protein expression in tumors of people with suspected non-small cell lung cancer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.